Denali Therapeutics, Inc. (DNLI)

20.93 +2.33 (+12.53%) USD  |  NASDAQ  |  Jan 22, 16:00
20.93 0.00 (0.00%) After-Hours: 06:30
More

Denali Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Enovis Corp. Upgrade
Masimo Corp. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade